These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 27106917

  • 1. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K.
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [Abstract] [Full Text] [Related]

  • 2. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T, Shah S, Shah J, Jacobsen G, Khandelwal A.
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH, Liu Y, Zhou YL, He PC, Yu DQ, Li LW, Xie NJ, Guo W, Tan N, Chen JY.
    Am J Cardiol; 2016 Jun 15; 117(12):1896-903. PubMed ID: 27161818
    [Abstract] [Full Text] [Related]

  • 4. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
    Pyxaras SA, Sinagra G, Mangiacapra F, Perkan A, Di Serafino L, Vitrella G, Rakar S, De Vroey F, Santangelo S, Salvi A, Toth G, Bartunek J, De Bruyne B, Wijns W, Barbato E.
    Am J Cardiol; 2013 Mar 01; 111(5):684-8. PubMed ID: 23261003
    [Abstract] [Full Text] [Related]

  • 5. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
    Han B, Li Y, Dong Z, Wan Q, Shen H, Li J, Wei M, Shen C.
    Heart Vessels; 2018 Oct 01; 33(10):1149-1158. PubMed ID: 29704102
    [Abstract] [Full Text] [Related]

  • 6. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
    Güngör B, Karataş MB, İpek G, Özcan KS, Çanga Y, Onuk T, Keskin M, Hayıroğlu Mİ, Karadeniz FÖ, Sungur A, Öztürk R, Bolca O.
    Ren Fail; 2016 Sep 01; 38(8):1167-73. PubMed ID: 27436614
    [Abstract] [Full Text] [Related]

  • 7. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):878-85. PubMed ID: 23703775
    [Abstract] [Full Text] [Related]

  • 8. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):198-201. PubMed ID: 20949583
    [Abstract] [Full Text] [Related]

  • 9. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, Stabryła-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.
    Kardiol Pol; 2007 Jun 01; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [Abstract] [Full Text] [Related]

  • 10. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T.
    Cardiovasc Revasc Med; 2013 Jun 01; 14(5):253-7. PubMed ID: 23993293
    [Abstract] [Full Text] [Related]

  • 11. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G, Bozbay M, Açıkgöz SK, Altay S, Uğur M, Köroğlu B, Uyarel H.
    Cardiol J; 2015 Jun 01; 22(1):101-7. PubMed ID: 24671903
    [Abstract] [Full Text] [Related]

  • 12. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A, Duran M.
    Clin Cardiol; 2017 Apr 01; 40(4):235-242. PubMed ID: 28244599
    [Abstract] [Full Text] [Related]

  • 13. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.
    Am J Cardiol; 2015 Sep 01; 116(5):711-6. PubMed ID: 26116992
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
    Ismail MD, Jalalonmuhali M, Azhari Z, Mariapun J, Lee ZV, Zainal Abidin I, Wan Ahmad WA, Zuhdi ASM, NCVD-PCI investigators.
    BMC Cardiovasc Disord; 2018 Sep 24; 18(1):184. PubMed ID: 30249197
    [Abstract] [Full Text] [Related]

  • 15. Association Between Acidosis Soon After Reperfusion and Contrast-Induced Nephropathy in Patients With a First-Time ST-Segment Elevation Myocardial Infarction.
    Gohbara M, Hayakawa A, Akazawa Y, Furihata S, Kondo A, Fukushima Y, Tomari S, Endo T, Kimura K, Tamura K.
    J Am Heart Assoc; 2017 Aug 23; 6(8):. PubMed ID: 28835362
    [Abstract] [Full Text] [Related]

  • 16. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T, Tanık VO, Aruğaslan E, Karabağ Y, Çağdaş M, Rencüzoğulları İ, Keskin M.
    Cardiovasc Interv Ther; 2019 Jul 23; 34(3):207-215. PubMed ID: 30191494
    [Abstract] [Full Text] [Related]

  • 17. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Lee SH, Gwon HC.
    Am J Cardiol; 2014 Dec 15; 114(12):1830-5. PubMed ID: 25438909
    [Abstract] [Full Text] [Related]

  • 18. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM, Yang DC, Haider MA, Swaminathan RV, Kim LK, Charitakis K, Tanoue M, Minutello RM, Gade CL, Singh HS, Bergman G, Wong SC, Feldman DN.
    J Invasive Cardiol; 2015 Nov 15; 27(11):490-6. PubMed ID: 25999136
    [Abstract] [Full Text] [Related]

  • 19. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Park SH, Jeong MH, Park IH, Choi JS, Rhee JA, Kim IS, Kim MC, Cho JY, Sim DS, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.
    Int J Cardiol; 2016 Jun 01; 212():100-6. PubMed ID: 27045874
    [Abstract] [Full Text] [Related]

  • 20. Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
    Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, Yamamoto N, Arima Y, Yamamoto E, Kaikita K, Tsujita K.
    J Am Heart Assoc; 2019 Dec 03; 8(23):e014096. PubMed ID: 31766973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.